中华行为医学与脑科学杂志
中華行為醫學與腦科學雜誌
중화행위의학여뇌과학잡지
CHINESE JOURNAL OF BEHAVIORAL MEDICINE AND BRAIN SCIENCE
2015年
4期
319-322
,共4页
宗小芬%胡茂林%唐劲松%李宗昌%陈晓岗%方润领
宗小芬%鬍茂林%唐勁鬆%李宗昌%陳曉崗%方潤領
종소분%호무림%당경송%리종창%진효강%방윤령
老年期抑郁症%载脂蛋白E%基因多态性%认知功能%血脂
老年期抑鬱癥%載脂蛋白E%基因多態性%認知功能%血脂
노년기억욱증%재지단백E%기인다태성%인지공능%혈지
Geriatric depression%Apolipoprotein E%Polymorphisms%Cognitive function%Serum lipid
目的 研究载脂蛋白E基因(apolipoprotein E gene,APOE)多态性与老年期抑郁症(geriatricdepression,GD)的关联,并探讨APOE基因型与患者抑郁症状、血脂水平及认知功能之间的关系.方法 采用单核苷酸多态性(single nucleotide polymorphism,SNP)位点检测技术检测120例GD患者及120例健康对照者APOE的rs7412及rs429358两多态性位点,分出各基因型;分析两组各基因型及等位基因频率差异;分析病例组APOE多态性与患者临床及人口学资料间的关系;采用Logistic多元回归分析各一般资料、临床资料对GD认知功能的影响.结果 两组基因型及各等位基因频率均差异无统计学意义(均P>0.05);携带ε4基因型的患者简易智能量表总分低于非携带者[(22.38±2.22)分,(25.28±2.28)分,t=3.091,P<0.01],而血脂水平TC(t=2.225,P<0.05)、LDL(t=2.728,P<0.01)高于非携带者;携带e4患者典型临床表现为阻滞(载荷0.695)和认知障碍(载荷0.902),而非携带者突出表现在焦虑躯体化因子(载荷0.990)和体质量因子(载荷0.864);GD认知损害的危险因子按作用大小依次为携带ε4的基因型(b '=1.097)、TC(b'=0.401).结论 APOE可能并非GD的发病因子;携带ε4基因型的患者认知功能差,血脂水平高;不同APOE基因型患者有不同的临床表现.
目的 研究載脂蛋白E基因(apolipoprotein E gene,APOE)多態性與老年期抑鬱癥(geriatricdepression,GD)的關聯,併探討APOE基因型與患者抑鬱癥狀、血脂水平及認知功能之間的關繫.方法 採用單覈苷痠多態性(single nucleotide polymorphism,SNP)位點檢測技術檢測120例GD患者及120例健康對照者APOE的rs7412及rs429358兩多態性位點,分齣各基因型;分析兩組各基因型及等位基因頻率差異;分析病例組APOE多態性與患者臨床及人口學資料間的關繫;採用Logistic多元迴歸分析各一般資料、臨床資料對GD認知功能的影響.結果 兩組基因型及各等位基因頻率均差異無統計學意義(均P>0.05);攜帶ε4基因型的患者簡易智能量錶總分低于非攜帶者[(22.38±2.22)分,(25.28±2.28)分,t=3.091,P<0.01],而血脂水平TC(t=2.225,P<0.05)、LDL(t=2.728,P<0.01)高于非攜帶者;攜帶e4患者典型臨床錶現為阻滯(載荷0.695)和認知障礙(載荷0.902),而非攜帶者突齣錶現在焦慮軀體化因子(載荷0.990)和體質量因子(載荷0.864);GD認知損害的危險因子按作用大小依次為攜帶ε4的基因型(b '=1.097)、TC(b'=0.401).結論 APOE可能併非GD的髮病因子;攜帶ε4基因型的患者認知功能差,血脂水平高;不同APOE基因型患者有不同的臨床錶現.
목적 연구재지단백E기인(apolipoprotein E gene,APOE)다태성여노년기억욱증(geriatricdepression,GD)적관련,병탐토APOE기인형여환자억욱증상、혈지수평급인지공능지간적관계.방법 채용단핵감산다태성(single nucleotide polymorphism,SNP)위점검측기술검측120례GD환자급120례건강대조자APOE적rs7412급rs429358량다태성위점,분출각기인형;분석량조각기인형급등위기인빈솔차이;분석병례조APOE다태성여환자림상급인구학자료간적관계;채용Logistic다원회귀분석각일반자료、림상자료대GD인지공능적영향.결과 량조기인형급각등위기인빈솔균차이무통계학의의(균P>0.05);휴대ε4기인형적환자간역지능량표총분저우비휴대자[(22.38±2.22)분,(25.28±2.28)분,t=3.091,P<0.01],이혈지수평TC(t=2.225,P<0.05)、LDL(t=2.728,P<0.01)고우비휴대자;휴대e4환자전형림상표현위조체(재하0.695)화인지장애(재하0.902),이비휴대자돌출표현재초필구체화인자(재하0.990)화체질량인자(재하0.864);GD인지손해적위험인자안작용대소의차위휴대ε4적기인형(b '=1.097)、TC(b'=0.401).결론 APOE가능병비GD적발병인자;휴대ε4기인형적환자인지공능차,혈지수평고;불동APOE기인형환자유불동적림상표현.
Objective To examine the association between the polymorphisms of apolipoprotein E gene (APOE) and geriatric depression (GD),and then conduct an exploratory investigation to analyse whether the APOE polymorphisms would relate to the depressive syndrome severity,the cognitive function,or the level of serum lipid in patients.Methods Participants,including 120 GD patients and 120 normal controls were enrolled to detect the two single nucleotide polymorphisms of APOE,rs7412 and rs429358 using the technology of SNP site testing.The frequency differences of genotype and allele were compared between the two groups.Then the association between APOE polymorphisms and clinical or demographic data of patients were clarified.The relationship between clinical or demographic data,and the cognitive function of GD patients were investigated using the Logistic multiple regression analysis.Results The frequency of APOE genotype and allele showed no significant difference between the two groups(P>0.05).Patients carrying e4 allen had significantly lower total scores of Man-Machine System Engineering((22.38±2.22) vs (25.28±2.28),t=3.091,P<0.01) and higher levels of TC (t=2.225,P< 0.05) and LDL(t=2.728,P<0.01) compared with those without ε4 allen.The specific symptoms of patients carrying e4 allen were cognitive impairment(load 0.902) and retardant factors(load 0.695),while patients without ε4 allen had characteristic symptoms of anxiety(load 0.990) and weight factors(load 0.864).Ranked by the effect power,the risk factors of cognitive impairment of GD patients are ε4(b'=1.097) and then TCTC (b'=0.401).Conclusions APOE may not modulate the susceptibility to GD.Patients carrying ε4 allen have severer cognitive impairment and higher levels of serum lipid.The different genotypes may lead to different clinical symptoms.